arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Inspire Medical Systems, Inc.

INSP
$66.53 ▲ +0.03 (+0.05%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
41 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
75
Health
Good
Bullish
auto_awesome

Analytical Summary

Inspire Medical Systems, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.9B
Dividend Yield —
Revenue Growth -7.9% ↘
Op. Margin -13.9% ↘
ROIC -3.4% ↘
FCF / Share $1.34 ↗
Trailing P/E —
Price / Book 2.3x
FCF Yield 2.0%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

41-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$206.69M
↓ -7.9% —
Net Income Profit after all expenses
$-11.29M
— 0.0% —
Operating Margin Operating profit as % of sales
-13.9%
↓ -5321.5% 44th
FCF / Share Free cash flow per share
$1.34
↑ +175.5% —
Long-Term Debt Long-term obligations
$21.40M
↓ -12.7% —
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
59
Returns
85
Financial Health
98
Cash Quality ↓
42

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 10 years · 41 quarters